2025 · 3rd Quarter (July 1 - Sep 30)
Filed by SPLITOAK STRATEGIES LLC.
Open official filingSource-reported fields
Literal source text
Role of molecular profiling in cancer care; access to molecular profiling technologies and multi-cancer testing in Medicare; HR 5081, Telehealth Modernization Act, prior authorization reform in Medicare and appropriate reimbursement for cutting edge cancer diagnostic testing
Literal federal measure citations: HR 5081
Role of Artificial Intelligence and technology in cancer diagnostics and treatment; Value of precision medicine and blood-based diagnostic tools; Appropriate standards in oversight of lab-developed tests
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.
